Provider payments and patient charges as policy tools for cost-containment: How successful are they in high-income countries?
Tóm tắt
In this paper, we focus on those policy instruments with monetary incentives that are used to contain public health expenditure in high-income countries. First, a schematic view of the main cost-containment methods and the variables in the health system they intend to influence is presented. Two types of instruments to control the level and growth of public health expenditure are considered: (i) provider payment methods that influence the price and quantity of health care, and (ii) cost-containment measures that influence the behaviour of patients. Belonging to the first type of instruments, we have: fee-for-service, per diem payment, case payment, capitation, salaries and budgets. The second type of instruments consists of patient charges and reference price systems for pharmaceuticals. Secondly, we provide an overview of experience in high-income countries that use or have used these particular instruments. Finally, the paper assesses the overall potential of these instruments in cost-containment policies.
Tài liệu tham khảo
Gray G: Access to medical care under strain: new pressures in Canada and Australia. Journal of Health Politics, Policy and Law. 1998, 23 (6): 905-947.
Feldstein P: Health Care Economics. Albany: Delmar Publishers. 1999
Rice T: The Economics of Health Reconsidered. Chicago: Health Administration Press. 1998
Greenfield S: Variations in resource utilization among medical specialties and systems of care. JAMA. 1992, 267 (12): 1624-1630. 10.1001/jama.267.12.1624.
Gerdtham UG, Jonsson B: International comparisons of health expenditure: theory, data and econometric analysis. In Handbook of health economics. Edited by: Culyer AJ, Newhouse JP. 2000, Amsterdam: Elsevier, 1A: 11-53.
Ikegami N, Campbell JC: Medical care in Japan. The New England Journal of Medicine. 1995, 333 (19): 1295-1299. 10.1056/NEJM199511093331922.
World Health Organization: The World Health Report 2001. Geneva. 2001
Ikegami N, Campbell JC: The art of balance in health policy: maintaining Japan's low-cost, egalitarian system. New York: Cambridge University Press. 1998
Mossialos E, Le Grand J: Cost Containment in the EU: an overview. In Health care and cost containment in the European Union. Edited by: Mossialos E, Le Grand J. 1999, Aldershot: Ashgate Publishing Ltd, 1-154.
Crainich D, Closon MC: Cost containment and health care reform in Belgium. In Health care and cost containment in the European Union. Edited by: Mossialos E, Le Grand J. 1999, Aldershot: Ashgate Publishing Ltd, 219-266.
Barer ML, Lomas J, Sanmartin C: Re-minding our Ps and Qs: Medical cost controls in Canada. Health Affairs. 1996, 15 (2): 216-234. 10.1377/hlthaff.15.2.216.
Canada's Health Care System. [http://www.hc-sc.gc.ca/]
European Observatory on Health Care Systems Health Care Systems in Transition: Belgium. Copenhagen. 2000
Coulam RF, Gaumer GL: Medicare's prospective payment system: a critical appraisal. Health Care Financing Review, Annual. Suppl: 45-77.
Schulenbury JM: Forming and reforming the market for third-party purchasing of health care:. Social Science and Medicine. 1994, 39 (10): 1473-81. 10.1016/0277-9536(94)90241-0.
Miller M: Service mix in the hospital outpatient department: implications for Medicare payment reform. Health Services Research. 1995, 30 (1): 59-77.
Carroll NV, Erwin WG: Patient shifting as a response to Medicare prospective payment. Medical Care. 1987, 25: 1161-7.
Järvelin J: Health care systems in transition. Finland: WHO, Copenhagen. 2002
Tabbush V, Swanson G: Changing paradigms in medical payment. Archives of Internal Medicine. 1996, 156: 357-60. 10.1001/archinte.156.4.357.
Miller R, Luft H: Managed Care Performance since 1980: A literature analysis. Journal of the American Medical Association. 1994, 1512-1519. 10.1001/jama.271.19.1512.
Sullivan K: On the 'efficiency' of managed care plans. Health Affairs. 2000, 139-148. 10.1377/hlthaff.19.4.139.
Gosden T, Pedersen L, Torgerson D: How should we pay doctors? A systematic review of salary payments and their effect on doctor behaviour. Q J Med. 1999, 92: 47-55. 10.1093/qjmed/92.1.47.
Jegers M, Kesteloot K, De Graeve D, Gilles W: A typology for provider payment systems in health care. Health Policy. 2002, 60 (3): 255-273. 10.1016/S0168-8510(01)00216-0.
Redmon P, Yakoboski P: The nominal and real effects of hospital budgets in France. Inquiry. 1995, 32: 174-183.
Bloor K, Freemantle N: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors. British Medical Journal. 1996, 312: 1525-1527.
Schöffski O, Schulenberg JM, Graf von der: Unintended effects of a cost-containment policy: results of a natural experiment in Germany. Social Science and Medicine. 1997, 45 (10): 1537-1539. 10.1016/S0277-9536(97)00090-7.
European Observatory on Health Care Systems: Health Care Systems in Transition. United Kingdom. WHO Copenhagen.
Brook H, Ware JE, Rogers WE: Does free care improve adults' health?. New England Journal of Medicine. 1983, 309 (23): 1426-34.
Andersen R, Smedby B, Vagero D: Cost containment, solidarity and cautious experimentation: Swedish dilemmas. Social Science and Medicine. 2001, 52: 1195-1204. 10.1016/S0277-9536(00)00239-2.
Zweifel P, Manning WG: Moral hazard and consumer incentives in health care. In Handbook of Health Economics. Edited by: Culyer AJ, Newhouse JP. 2000, Amsterdam: North Holland, 1A: 409-459.
Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P: Effects of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. New England Journal of Medicine. 1994, 331: 650-655. 10.1056/NEJM199409083311006.
OECD: OECD Health Data 2001 Comparative Analysis of 30 Countries. Paris: OECD. 2001
Poullier JP: Administrative costs in selected industrialized countries. Health Care Financing Review. 1992, 13 (4): 167-172.
Ministry of Health and Welfare, Japan: Outline of Social Insurance in Japan. Tokyo. 1999
Kass DI, Pautler PA: The administrative costs of non-profit health insurers. Economic Inquiry. 1981, 29 (3): 515-521.
Duriez M: Le système de santé en France. Paris: Haut Comité de Santé Publique. 2000
Ikegami N, Campbell JC: Health care reform in Japan: The virtues of muddling through. Health Affairs. 1999, 18 (3): 56-75. 10.1377/hlthaff.18.3.56.
Freemantle N, Bloor K: Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients. British Medical Journal. 1996, 312: 1469-1471.